Viewing Study NCT00087503


Ignite Creation Date: 2025-12-24 @ 7:10 PM
Ignite Modification Date: 2025-12-27 @ 10:26 PM
Study NCT ID: NCT00087503
Status: COMPLETED
Last Update Posted: 2008-04-01
First Post: 2004-07-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module